Madiha manages the Phenomics Australia node at the University of Queensland

Responsible for generation, genetic manipulation, reporter gene creation and insertion, as well as differentiation into the bespoke cell and organoid models for the clients of the UQ-node of Phenomics Australia

Madiha is a Postdoctoral Research Fellow at the Australian Institute for Bioengineering and Nanotechnology (AIBN) at The University of Queensland. Madiha completed her PhD at the University of Sydney, specialising in cancer cell biology. Her research was carried out as a part of the Bill Walsh Translational Cancer Laboratory and investigated the effect of Regorafenib, a multi-targeting tyrosine kinase inhibitor, in gastric cancer. Her research utilised advanced techniques of 3D tumour spheroids, live cell imaging, high-throughput immunoassays, immunofluorescence, immunohistochemistry and proteomics. As a member of the leading research arm of the Medical Oncology department at the Royal North Shore Hospital, she participated in clinical collaborations as well. She also holds an Honours degree in Biomedical Engineering, with a focus on medical Imaging, biomaterials, and tissue engineering. 

Madiha now manages the In Vitro Genome Engineering and Disease Modelling service at the AIBN under the leadership of Professor Wolvetang for Phenomics Australia. Her tasks involve providing bespoke solutions for Australian researchers and industry to assist in the tailoring and optimising of cell-culture format using pluripotent stem cells to study and test the impact of genetic mutations on disease. She also assists with a broad panel of in vivo and in vitro genome engineering and disease modelling, functional genomics and high-throughput screening, biobanking and pathology services and technical expertise, for discovery and a new understanding of the molecular basis of disease to benefit all Australians.